Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Schering-Plough has posted a net income of $398 million for the second quarter of 2008, compared with $517 million for the same quarter in 2007.
Subscribe to our email newsletter
The company attributed the lower second quarter earnings to the acquisition of biotech group Organon BioSciences.
The company posted net sales of $4.9 billion in the second quarter of 2008, up 55%, compared to $3.18 billion in the second quarter of 2007.
Fred Hassan, chairman and CEO of Schering-Plough, said: “We are very pleased to see another quarter of strong performance and broad-based growth for our company. Through the action agenda we launched in 2003, we were determined to diversify our company and to build a deep Phase III pipeline.
“Today, we are succeeding on both fronts. Our Phase III pipeline is now the strongest in our company’s history, and the $16 billion acquisition of Organon BioSciences in November 2007 has already met its accretion target for 2008.”